Spero Therapeutics, Inc.

8-K Entered a material agreement; Took on a direct financial obligation; Regulation FD disclosure; Other events Jul 14, 2026 8-K Director or officer change; Amended charter or bylaws; Shareholder vote results Jun 25, 2026 8-K Regulation FD disclosure; Other events Jun 22, 2026 10-Q Quarter ended 2026-03-31 May 13, 2026 8-K Results of operations (earnings release) May 13, 2026 8-K Results of operations (earnings release) Mar 26, 2026 10-K Fiscal year ended 2025-12-31 Mar 26, 2026 8-K Director or officer change; Other events Jan 30, 2026 8-K Other events Dec 19, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Nov 13, 2025 10-Q Quarter ended 2025-09-30 Nov 13, 2025 10-Q Quarter ended 2025-06-30 Aug 12, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Aug 12, 2025 8-K Director or officer change; Shareholder vote results Jun 18, 2025 8-K Regulation FD disclosure; Other events May 28, 2025 8-K Results of operations (earnings release) May 13, 2025 10-Q Quarter ended 2025-03-31 May 13, 2025 8-K Director or officer change Apr 28, 2025 8-K Results of operations (earnings release) Mar 27, 2025 10-K Fiscal year ended 2024-12-31 Mar 27, 2025 8-K Delisting notice or listing-rule failure Feb 28, 2025 8-K Results of operations (earnings release); Director or officer change; Regulation FD disclosure; Other events Jan 10, 2025 8-K Results of operations (earnings release) Nov 14, 2024 10-Q Quarter ended 2024-09-30 Nov 14, 2024 8-K Results of operations (earnings release); Exit or disposal costs; Regulation FD disclosure; Other events Oct 29, 2024 8-K Regulation FD disclosure Sep 10, 2024 10-Q Quarter ended 2024-06-30 Aug 5, 2024 8-K Results of operations (earnings release); Regulation FD disclosure Aug 5, 2024 8-K Director or officer change; Shareholder vote results Jun 3, 2024 8-K Results of operations (earnings release) May 15, 2024 10-Q Quarter ended 2024-03-31 May 15, 2024 8-K Other events Mar 29, 2024 10-K Fiscal year ended 2023-12-31 Mar 13, 2024 8-K Results of operations (earnings release) Mar 13, 2024 8-K Director or officer change Feb 9, 2024 8-K Regulation FD disclosure Jan 8, 2024 8-K Results of operations (earnings release); Regulation FD disclosure; Other events Jan 5, 2024 8-K Regulation FD disclosure; Other events Jan 2, 2024 8-K Results of operations (earnings release) Nov 13, 2023 10-Q Quarter ended 2023-09-30 Nov 13, 2023